(0.09%) 5 521.75 points
(0.12%) 39 890 points
(0.20%) 19 791 points
(0.01%) $81.64
(0.46%) $2.82
(-0.32%) $2 337.00
(0.00%) $29.53
(0.23%) $1 004.10
(0.03%) $0.932
(0.00%) $10.53
(0.02%) $0.788
(-0.85%) $87.25
2.63% $ 39.00
Live Chart Being Loaded With Signals
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications...
Stats | |
---|---|
Dzisiejszy wolumen | 458 134 |
Średni wolumen | 457 679 |
Kapitalizacja rynkowa | 2.28B |
EPS | $-0.640 ( Q1 | 2024-03-31 ) |
Następna data zysków | ( $-0.640 ) 2024-08-26 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0870 (0.22%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-29 | Fairmount Funds Management Llc | Buy | 51 166 | Common Stock |
2024-01-29 | Fairmount Funds Management Llc | Sell | 892 529 | Common Stock |
2023-12-18 | Henderson Michael Thomas | Buy | 398 512 | Stock Option (Right to Buy) |
2023-07-13 | Fairmount Funds Management Llc | Buy | 1 992 734 | Common Stock |
2023-07-13 | Fairmount Funds Management Llc | Buy | 892 529 | Common Stock |
INSIDER POWER |
---|
46.08 |
Last 9 transactions |
Buy: 3 438 612 | Sell: 892 529 |
Wolumen Korelacja
Apogee Therapeutics, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
OZEM | 1 |
CNJFX | 0.941 |
OCEA | 0.939 |
DYFI | 0.931 |
RUMBW | 0.928 |
FSAVX | 0.926 |
PMNT | 0.924 |
ATXS | 0.923 |
NGNE | 0.92 |
HTOO | 0.918 |
10 Najbardziej negatywne korelacje | |
---|---|
NEWZ | -0.924 |
CCSB | -0.919 |
DTI | -0.918 |
GECCI | -0.915 |
IPXX | -0.912 |
BAYA | -0.911 |
EVERX | -0.909 |
SARK | -0.897 |
EAPCX | -0.893 |
BKHAU | -0.89 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Apogee Therapeutics, Inc. Korelacja - Waluta/Towar
Apogee Therapeutics, Inc. Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-1.660 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-1.660 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-0.790 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej